A case of interstitial lung disease following Oxford-AstraZeneca COVID-19 vaccination.
作者信息
Taverner Joshua Valentine Baker, Robertson James Gordon
机构信息
Western Health, Melbourne, Victoria, Australia.
Albury Wodonga Health, Wodonga, Victoria, Australia.
出版信息
Intern Med J. 2022 Jul;52(7):1276-1277. doi: 10.1111/imj.15850.
Abstract
摘要
相似文献
1
A case of interstitial lung disease following Oxford-AstraZeneca COVID-19 vaccination.
Intern Med J. 2022 Jul;52(7):1276-1277. doi: 10.1111/imj.15850.
2
Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
Nephrology (Carlton). 2022 Jan;27(1):109-110. doi: 10.1111/nep.13993. Epub 2021 Nov 9.
3
Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination.
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(3):445. doi: 10.25259/IJDVL_819_2021.
4
Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.
5
Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
Clin Exp Dermatol. 2022 Jan;47(1):175-176. doi: 10.1111/ced.14898. Epub 2021 Aug 31.
6
Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
Am J Emerg Med. 2022 Jan;51:427.e3-427.e4. doi: 10.1016/j.ajem.2021.07.011. Epub 2021 Jul 8.
7
A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible interstitial lung injury post-vaccination.
Infect Dis (Lond). 2022 Sep;54(9):692-697. doi: 10.1080/23744235.2022.2072521. Epub 2022 May 12.
8
Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.
J Cosmet Dermatol. 2022 Jun;21(6):2311-2314. doi: 10.1111/jocd.14945. Epub 2022 Apr 9.
9
Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.
Lancet Glob Health. 2022 Jan;10(1):e33-e34. doi: 10.1016/S2214-109X(21)00545-3.
10
Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford-AstraZeneca) Vaccination.
Cardiovasc Intervent Radiol. 2022 Mar;45(3):398-401. doi: 10.1007/s00270-021-03053-3. Epub 2022 Jan 18.
本文引用的文献
1
Interstitial pneumonitis after COVID-19 vaccination: A report of three cases.
Allergol Int. 2022 Apr;71(2):251-253. doi: 10.1016/j.alit.2021.10.003. Epub 2021 Nov 9.
2
A case of severe interstitial lung disease after COVID-19 vaccination.
QJM. 2022 Jan 5;114(11):805-806. doi: 10.1093/qjmed/hcab263.
3
Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination.
Thorax. 2022 Jan;77(1):9-10. doi: 10.1136/thoraxjnl-2021-217985. Epub 2021 Sep 11.
4
COVID-19 vaccine-related interstitial lung disease: a case study.
Thorax. 2022 Jan;77(1):102-104. doi: 10.1136/thoraxjnl-2021-217609. Epub 2021 Aug 6.
5
Drug-Induced Interstitial Lung Disease: A Systematic Review.
J Clin Med. 2018 Oct 15;7(10):356. doi: 10.3390/jcm7100356.
Zotero 插件